The Board has ordered additional development due to the need for compliance with the Veterans Claims Assistance Act of 2000 (VCAA). The claims are being remanded to allow for a review and consideration of all evidence, including any new evidence received since the last supplemental statement of the case. The RO must ensure that all VCAA notification and development action has been taken.
The deciding factor: The Board is required by the VCAA to ensure that all necessary development has been conducted and that the claims are considered in light of the VCAA.
- Claimed conditions
- tinea versicolor, skin growths
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- May 21, 2003
- Citation
- 0309523
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0309523.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board is remanding the claim for tinea versicolor to ensure that VA fulfills its duty to assist by obtaining private medical records and potentially scheduling a new examination.
- Granted
The Board granted service connection for enlarged liver (fatty infiltration), benign prostate hypertrophy, and tinea versicolor as secondary to the Veteran's service-connected diabetes mellitus, type II.
- Partly granted
The Board granted readjudication for the claims of service connection for left foot hallux valgus and tinea versicolor, but denied the claims for tinea corporis, tinea cruris, carbuncle, cyst, and scarring secondary to tinea versicolor.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.